Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window VANCOUVER -- ...

More than 15 years of research led by neurologists at the University of Rochester Medical Center (URMC) has culminated in the first approved treatment for individuals with a rare neuromuscular ...

In the past 15 years, Ryan Csupak has been in an emergency room 30 to 40 times, unable to move his legs and arms. He’s experienced shortness of breath, extreme fatigue and weakness. This is the ...

Thyrotoxicosis can lead to thyrotoxic periodic paralysis (TPP), an endocrine channelopathy, and is the most common cause of acquired periodic paralysis. Typically, paralytic attacks cease when ...

Taro announced the launch of Keveyis (dichlorphenamide) tablets, the first therapy approved for the treatment of primary hyperkalemic and hypokalemic periodic paralysis and related variants. Keveyis ...

This infrequent neuromuscular disorder is commonly mistaken for a multitude of other disorders, but diagnosis can be confirmed with key clues and genetic testing.

Scientists have identified a gene underlying a disease that causes temporary paralysis of skeletal muscle. The finding, they say, illustrates how investigations of rare genetic diseases can drive ...

Taro announced that the Food and Drug Administration (FDA) has approved Keveyis (dichlorphenamide) tablets for the treatment of primary hyperkalemic and hypokalemic periodic paralysis. Keveyis is the ...

Gamstorp specifically excluded clinical myotonia from her syndrome: "The typical inability to relax after a muscle contraction in myotonia congenita is not seen during or between attacks of adynamia ...

Thyrotoxic periodic paralysis is a rare but potentially life‐threatening complication of thyrotoxicosis characterised by hypokalaemia‐induced flaccid paralysis due to an intracellular potassium shift ...

Primary Periodic Paralysis is a rare genetic condition impacting 3,000-4,000 Americans characterized by repeated episodes of extreme muscle weakness or temporary paralysis, often triggered by specific ...